Silk Road Medical, Inc.

Silk Road Medical, Inc. is a medical device company based in Sunnyvale, California. The company specializes in reducing stroke risk by treating carotid artery disease through its innovative transcarotid artery revascularization (TCAR) approach. This method combines minimally invasive direct carotid access with high-rate blood flow reversal, protecting the brain during the procedure. TCAR integrates advanced endovascular techniques with traditional surgical principles, demonstrating reduced morbidity and mortality compared to conventional methods. Silk Road Medical offers a range of products that support the TCAR procedure, including the ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, and ENROUTE 0.014” Guidewire. These products are specifically designed to treat carotid artery disease and are marketed under the Enroute and Enhance brand names. The company aims to establish TCAR as the new standard of care in the U.S. market, focusing on improving patient outcomes with safer, less invasive alternatives to traditional surgical methods.

• Employees 480
• Founded 2007
• Annual Revenue $177134000
• Total Funding $567517867